V

    Vir Biotechnology Inc (VIR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $10.94
    +0.11 (+1.02%)

    Market Cap: $1.97B

    Last updated: Sep 02, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    38%(11/29)
    Avg Surprise
    -8.19%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.75
    Range$-0.95 - $-0.58
    8 analysts
    EPS Revisions
    2
    0
    7d
    2
    2
    30d
    EPS Estimate Drift
    90d ago$-0.78-4.7%
    60d ago$-0.81-8.2%
    30d ago$-0.81-8.2%
    7d ago$-0.81-8.2%
    Current$-0.75
    Revenue Consensus
    $865120
    Range$0 - $3M
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-2.24
    Range$-2.68 - $-1.83
    8 analysts
    Revenue Consensus
    $-87373310
    Range$-93781120 - $-73420120
    9 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-2.24---
    Sep 26EST
    		-$-0.75---
    Jun 26
    Reported Aug 5
    		$0.47$0.83-43.37%Miss+158.8%
    Mar 26
    Reported May 6
    		$-0.85$0.48-277.08%Miss+3.4%
    Dec 25
    Reported Feb 23
    		$-0.31$-0.54+42.59%Beat+59.2%
    Sep 25
    Reported Nov 5
    		$-1.17$-0.70-67.14%Miss+25.0%
    Jun 25
    Reported Aug 6
    		$-0.80$-0.72-11.11%Miss+21.6%
    Mar 25
    Reported May 7
    		$-0.88$-0.84-4.76%Miss-83.3%
    Dec 24
    Reported Feb 26
    		$-0.76$-0.89+14.61%Beat+11.6%
    Sep 24
    Reported Oct 31
    		$-1.56$-1.08-44.44%Miss-27.9%
    Jun 24
    Reported Aug 1
    		$-1.02$-0.89-14.61%Miss+29.7%
    Mar 24
    Reported May 2
    		$-0.48N/A+54.29%Beat+54.7%
    Dec 23
    Reported Feb 22
    		$-0.86$-1.01+14.85%Beat-13.2%
    Sep 23
    Reported Nov 2
    		$-1.22$-1.19-2.52%Miss-193.8%
    Jun 23
    Reported Aug 3
    		$-1.45$-1.19-21.85%Miss-150.0%
    Mar 23
    Reported May 4
    		$-1.06$-0.86-23.26%Miss-127.5%
    Dec 22
    Reported Feb 23
    		$-0.76$-0.39-94.87%Miss-119.4%
    Sep 22
    Reported Nov 3
    		$1.30$-0.31+519.35%Beat+58.5%
    Jun 22
    Reported Aug 9
    		$-0.58$0.46-226.09%Miss-226.1%
    Mar 22
    Reported May 5
    		$3.85$3.62+6.35%Beat+391.7%
    Dec 21
    Reported Feb 24
    		$3.92$3.04+28.95%Beat+572.3%
    Sep 21
    Reported Nov 4
    		$0.82$0.09+811.11%Beat+222.4%
    Jun 21
    Reported Aug 5
    		$0.46$-0.40+215.00%Beat+270.4%
    Mar 21
    Reported May 6
    		$-1.32$-0.11-1100.00%Miss-85.9%
    Dec 20
    Reported Feb 25
    		$-0.83$-0.70-18.57%Miss-20.3%
    Sep 20
    Reported Nov 10
    		$-0.67$-0.60-11.67%Miss+85.4%
    Jun 20
    Reported Aug 11
    		$-0.27N/A+56.45%Beat+47.1%
    Mar 20
    Reported May 12
    		$-0.71$-0.56-26.79%Miss-
    Dec 19
    Reported Mar 26
    		$-0.69$-0.67-2.99%Miss-
    Sep 19
    Reported Oct 10
    		$-4.60$-3.33-38.14%Miss-
    Jun 19
    Reported Sep 3
    		$-0.51$-0.71+28.17%Beat-

    Key Metrics

    Valuation
    P/E Ratio-5.88EV/EBITDA0.90x
    Price/FCF-9.01xFCF Yield-11.10%
    Profitability
    Profit Margin-83.00%Operating Margin30.70%
    ROE-26.10%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio6.04xQuick Ratio6.04x
    Trading Statistics
    Beta1.59Avg Volume1.72M
    52-Week High$11.7452-Week Low$4.75

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$10.30
    SMA 20$9.67
    SMA 50$9.61
    SMA 200$8.47
    EMA 10$10.42
    EMA 20$9.97
    EMA 50$9.60
    EMA 200$8.63

    MACD

    Line: 0.46Signal: 0.26Hist: 0.20

    ADX

    ADX: 26.7+DI: 27.9-DI: 12.3

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down4.0
    PSAR$9.34

    Bollinger Bands

    Upper Band$11.35
    Lower Band$7.98
    %B Position3491%(Upper)
    Band Width0.88

    RSI (14-Day)

    Neutral
    66.0

    Momentum Oscillators

    Stoch %K83.8
    Stoch %D86.6
    Williams %R-19.5
    ROC (10d)16.5%
    Momentum1.55
    CCI (20d)127.2
    MFI (14d)74.7

    Volatility Measures

    ATR (14d)$0.56(5.1%)
    StdDev (20d)0.84
    Hist Vol50.8%(High)

    Volume Flow

    VWAP$10.92
    OBV41.4M
    AD Line-24.4M
    CMF (20d)0.106

    Volume Metrics

    Avg Vol (20d)1.7M
    Vol Ratio1.8x(High)
    VWMA (20d)$9.82

    Pivot Points

    R3$11.93
    R2$11.69
    R1$11.26
    Pivot Point$11.03
    S1$10.60
    S2$10.36
    S3$9.93

    Advanced Oscillators

    TSI27.14
    Ultimate Osc62.8
    KST95.36

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$238.95M$0$64.31M$0$1.21M$3.03M$12.37M$2.38M$3.08M$56.38M$16.79M$2.64M
    Cost of Revenue$0$0$15,000$0$11,000$0$684,000$50,000$52,000$59,000$798,000$38,000
    Gross Profit$238.95M$0$64.30M$0$1.20M$3.03M$11.69M$2.33M$3.02M$56.32M$15.99M$2.60M
    Operating Expenses$165.48M$132.26M$111.97M$173.69M$119.62M$142.58M$128.84M$233.63M$161.65M$136.40M$155.00M$189.33M
    R&D$135.28M$108.92M$88.35M$151.46M$97.51M$118.64M$106.08M$195.18M$105.11M$100.13M$108.97M$145.03M
    SG&A$30.20M$23.34M$23.62M$22.23M$22.28M$23.94M$26.70M$25.74M$30.27M$36.32M$41.22M$40.93M
    Operating Income$73.47M$-132,290,000$-47,921,000$-173,443,000$-118,417,000$-139,547,000$-117,150,000$-231,304,000$-158,630,000$-80,081,000$-139,016,000$-186,732,000
    Interest Income$8.97M$7.19M$7.80M$9.36M$10.79M$12.29M$14.15M$17.53M$18.85M$21.28M$0$21.93M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$80.26M$-125,525,000$-43,060,000$-162,973,000$-110,788,000$-120,949,000$-104,675,000$-213,540,000$-139,890,000$-65,000,000$-120,757,000$-166,626,000
    Income Tax Expense$179,000$170,000$-137,000$168,000$170,000$16,000$-86,000$177,000$-1,512,000$276,000$-4,784,000$-3,213,000
    Net Income$80.08M$-125,695,000$-42,923,000$-163,141,000$-110,958,000$-120,965,000$-104,589,000$-213,717,000$-138,378,000$-65,276,000$-115,973,000$-163,413,000
    EBITDA$74.42M$-129,509,000$-46,415,000$-168,023,000$-116,135,000$-126,281,000$-113,774,000$-227,817,000$-151,839,000$-81,528,000$-135,663,000$-181,662,000
    EBIT$71.29M$-132,714,000$-50,862,000$-172,336,000$-121,573,000$-133,237,000$-118,828,000$-231,067,000$-158,736,000$-86,283,000$-141,493,000$-188,557,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about VIR

    Government Contracts

    Gov Obligations (TTM)
    -$8.36M
    Gov Obligations / Revenue
    -12.8%
    Obligations YoY
    80.1%
    Active Awards
    1
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Vir Biotechnology (NASDAQ:VIR) Trading 4.8% Higher - Here's What Happened

    Vir Biotechnology (NASDAQ:VIR) shares increased by 4.8% to $11.46 on Tuesday, despite trading volume being 88% below average. The company has a "Moderate Buy" consensus rating and an average price target of $21.57 from analysts. This positive movement follows Vir Biotechnology exceeding its quarterly earnings expectations, reporting adjusted EPS of $0.47 and revenue of $238.95 million, significantly above forecasts.

    MarketBeat•9/1/26•
    Bullish

    BlackRock Inc. Purchases New Position in Vir Biotechnology, Inc. $VIR

    BlackRock Inc. has acquired a significant new position in Vir Biotechnology, Inc., purchasing over 20 million shares valued at approximately $210.7 million, giving it a 12.26% stake. Other institutional investors have also adjusted their holdings, with 65.32% of the stock now owned by institutions. Despite a positive analyst outlook with a "Moderate Buy" rating and strong quarterly earnings that beat estimates, the company remains unprofitable.

    MarketBeat•8/29/26•
    Somewhat-Bullish

    Algert Global LLC Purchases 315,969 Shares of Vir Biotechnology, Inc. $VIR

    Algert Global LLC increased its stake in Vir Biotechnology (NASDAQ:VIR) by 64.6% in the second quarter, purchasing an additional 315,969 shares. The firm now holds 804,977 shares valued at $8.2 million. Despite reporting strong quarterly earnings that beat estimates, the company continues to show substantial losses, with a negative net margin of 638.88%.

    MarketBeat•8/28/26•
    Somewhat-Bullish

    Vir Biotechnology unveils decade-long timeline spotlighting research advances and company culture

    Vir Biotechnology is celebrating its 10-year anniversary by releasing a timeline showcasing its scientific progress, company achievements, traditions, and employee contributions. The company recently reported over $1.0 billion in cash and advancing CHD and oncology pipelines in its second-quarter financial results. As part of its anniversary, Vir Biotechnology also hosted a Family Day, inviting relatives and friends to learn about its operations.

    Traders Union•8/28/26•
    Somewhat-Bullish

    ADAR1 Capital Management LLC Acquires New Shares in Vir Biotechnology, Inc. $VIR

    ADAR1 Capital Management LLC has acquired a new stake of 2,456,677 shares in Vir Biotechnology, Inc. (NASDAQ:VIR) during the second quarter, valued at approximately $25,034,000, making it their 17th largest position. Other institutional investors like BlackRock Inc. and Pictet Asset Management Holding SA have also adjusted their holdings in Vir Biotechnology. Analysts currently rate Vir Biotechnology as a "Moderate Buy" with a consensus target price of $20.62.

    MarketBeat•8/26/26•
    Somewhat-Bullish

    Frequently Asked Questions About VIR

    Does VIR pay dividends?
    Vir Biotechnology Inc (VIR) does not currently pay a regular dividend.
    What is VIR's market cap?
    Vir Biotechnology Inc (VIR) has a market capitalization of $1.97B with a current stock price of $10.94.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In